|
2024-02-21 |
2024-02-20 |
S
Sale
|
Audhya Paul K.
CHIEF MEDICAL OFFICER
Officer
|
14,295
-21.3%
14.12
201,774
USD
|
14,295
-21.3%
|
14.12
|
201,774
USD
|
|
|
2024-02-21 |
2024-02-20 |
S
Sale
|
Palleiko Benjamin L
CFO, CBO
Officer
|
22,802
-10.9%
14.11
321,846
USD
|
22,802
-10.9%
|
14.11
|
321,846
USD
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
Feener Edward P.
CHIEF SCIENTIFIC OFFICER
Officer
|
300
-0.5%
14.72
4,416
USD
|
300
-0.5%
|
14.72
|
4,416
USD
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
Feener Edward P.
CHIEF SCIENTIFIC OFFICER
Officer
|
19,591
-23.9%
14.04
274,991
USD
|
19,591
-23.9%
|
14.04
|
274,991
USD
|
|
|
2024-02-21 |
2024-02-20 |
S
Sale
|
Feener Edward P.
CHIEF SCIENTIFIC OFFICER
Officer
|
8,397
-9.3%
14.11
118,522
USD
|
8,397
-9.3%
|
14.11
|
118,522
USD
|
|
|
2024-02-21 |
2024-02-20 |
S
Sale
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Officer
|
12,053
-14.2%
14.11
170,124
USD
|
12,053
-14.2%
|
14.11
|
170,124
USD
|
|
|
2024-02-21 |
2024-02-20 |
S
Sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
24,888
-10.5%
14.11
351,289
USD
|
24,888
-10.5%
|
14.11
|
351,289
USD
|
|
|
2024-02-16 |
2024-02-14 |
S
Sale
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Officer
|
39,886
-37.6%
15.01
598,661
USD
|
39,886
-37.6%
|
15.01
|
598,661
USD
|
|
|
2024-02-16 |
2024-02-14 |
S
Sale
|
Palleiko Benjamin L
CFO, CBO
Officer
|
40,855
-20.4%
15.01
613,205
USD
|
40,855
-20.4%
|
15.01
|
613,205
USD
|
|
|
2024-02-16 |
2024-02-14 |
S
Sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
58,356
-24.3%
15.01
875,883
USD
|
58,356
-24.3%
|
15.01
|
875,883
USD
|
|
|
2024-02-16 |
2024-02-14 |
S
Sale
|
Feener Edward P.
CHIEF SCIENTIFIC OFFICER
Officer
|
28,171
-28.2%
15.01
422,827
USD
|
28,171
-28.2%
|
15.01
|
422,827
USD
|
|
|
2024-02-08 |
2024-02-08 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
29,747
+0.6%
14.70
437,281
USD
|
29,747
+0.6%
|
14.70
|
437,281
USD
|
|
|
2024-02-08 |
2024-02-07 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
51,827
+1.1%
14.56
754,601
USD
|
51,827
+1.1%
|
14.56
|
754,601
USD
|
|
|
2024-02-08 |
2024-02-06 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
4,474
+0.1%
14.74
65,947
USD
|
4,474
+0.1%
|
14.74
|
65,947
USD
|
|
|
2024-02-05 |
2024-02-01 |
PS
Planned sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
700
-0.6%
16.81
11,770
USD
|
700
-0.6%
|
16.81
|
11,770
USD
|
|
|
2024-02-05 |
2024-02-01 |
PS
Planned sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
9,300
-7.3%
16.18
150,428
USD
|
9,300
-7.3%
|
16.18
|
150,428
USD
|
|
|
2024-02-01 |
2024-01-30 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
88,099
+1.9%
14.47
1,274,793
USD
|
88,099
+1.9%
|
14.47
|
1,274,793
USD
|
|
|
2024-01-29 |
2024-01-29 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
80,600
+1.8%
14.22
1,146,132
USD
|
80,600
+1.8%
|
14.22
|
1,146,132
USD
|
|
|
2024-01-29 |
2024-01-26 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
4,174
+0.1%
12.98
54,179
USD
|
4,174
+0.1%
|
12.98
|
54,179
USD
|
|
|
2024-01-29 |
2024-01-25 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
7,030
+0.2%
12.73
89,492
USD
|
7,030
+0.2%
|
12.73
|
89,492
USD
|
|
|
2024-01-24 |
2024-01-24 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
20,686
+0.5%
12.44
257,334
USD
|
20,686
+0.5%
|
12.44
|
257,334
USD
|
|
|
2024-01-24 |
2024-01-23 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
10,897
+0.2%
12.54
136,648
USD
|
10,897
+0.2%
|
12.54
|
136,648
USD
|
|
|
2024-01-24 |
2024-01-22 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
67,546
+1.5%
12.55
847,702
USD
|
67,546
+1.5%
|
12.55
|
847,702
USD
|
|
|
2024-01-19 |
2024-01-19 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
25,000
+0.6%
12.43
310,750
USD
|
25,000
+0.6%
|
12.43
|
310,750
USD
|
|
|
2024-01-19 |
2024-01-18 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
39,680
+0.9%
12.51
496,397
USD
|
39,680
+0.9%
|
12.51
|
496,397
USD
|
|
|
2024-01-19 |
2024-01-17 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
78,925
+1.8%
12.60
994,455
USD
|
78,925
+1.8%
|
12.60
|
994,455
USD
|
|
|
2024-01-16 |
2024-01-16 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
19,599
+0.5%
12.73
249,495
USD
|
19,599
+0.5%
|
12.73
|
249,495
USD
|
|
|
2024-01-16 |
2024-01-11 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
6,647
+0.2%
12.68
84,284
USD
|
6,647
+0.2%
|
12.68
|
84,284
USD
|
|
|
2024-01-12 |
2024-01-11 |
PS
Planned sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
22,679
-36.3%
13.03
295,514
USD
|
22,679
-36.3%
|
13.03
|
295,514
USD
|
|
|
2024-01-10 |
2024-01-10 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
47,700
+1.1%
12.67
604,359
USD
|
47,700
+1.1%
|
12.67
|
604,359
USD
|
|
|
2024-01-10 |
2024-01-09 |
PS
Planned sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
100
-0.2%
13.00
1,300
USD
|
100
-0.2%
|
13.00
|
1,300
USD
|
|
|
2024-01-10 |
2024-01-09 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
20,816
+0.5%
12.56
261,449
USD
|
20,816
+0.5%
|
12.56
|
261,449
USD
|
|
|
2024-01-10 |
2024-01-08 |
PS
Planned sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
17,221
-21.6%
13.01
224,000
USD
|
17,221
-21.6%
|
13.01
|
224,000
USD
|
|
|
2024-01-10 |
2024-01-08 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
69,184
+1.7%
12.44
860,649
USD
|
69,184
+1.7%
|
12.44
|
860,649
USD
|
|
|
2024-01-05 |
2024-01-04 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
41,764
+1.0%
12.11
505,762
USD
|
41,764
+1.0%
|
12.11
|
505,762
USD
|
|
|
2024-01-05 |
2024-01-03 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
17,605
+0.4%
12.20
214,781
USD
|
17,605
+0.4%
|
12.20
|
214,781
USD
|
|
|
2023-12-29 |
2023-12-29 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
6,013
+0.1%
12.49
75,102
USD
|
6,013
+0.1%
|
12.49
|
75,102
USD
|
|
|
2023-12-29 |
2023-12-28 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
471,490
+13.0%
12.50
5,893,625
USD
|
471,490
+13.0%
|
12.50
|
5,893,625
USD
|
|
|
2023-12-29 |
2023-12-27 |
B
Purchase
|
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
|
41,514
+1.2%
11.97
496,923
USD
|
41,514
+1.2%
|
11.97
|
496,923
USD
|
|
|
2023-12-28 |
2023-12-27 |
PS
Planned sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
30,000
-19.0%
12.02
360,453
USD
|
30,000
-19.0%
|
12.02
|
360,453
USD
|
|
|
2023-11-21 |
2023-11-20 |
S
Sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
4,958
-5.8%
8.23
40,801
USD
|
4,958
-5.8%
|
8.23
|
40,801
USD
|
|
|
2023-11-21 |
2023-11-20 |
S
Sale
|
Palleiko Benjamin L
President, CFO, CBO & Sec'y
Officer
|
13,008
-10.4%
8.23
107,047
USD
|
13,008
-10.4%
|
8.23
|
107,047
USD
|
|
|
2023-11-21 |
2023-11-20 |
S
Sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
14,807
-8.6%
8.23
121,851
USD
|
14,807
-8.6%
|
8.23
|
121,851
USD
|
|
|
2023-11-21 |
2023-11-20 |
S
Sale
|
Audhya Paul K.
Chief Medical Officer
Officer
|
7,985
-17.9%
8.23
65,711
USD
|
7,985
-17.9%
|
8.23
|
65,711
USD
|
|
|
2023-11-21 |
2023-11-20 |
S
Sale
|
Yea Christopher
Chief Development Officer
Officer
|
7,113
-13.4%
8.23
58,535
USD
|
7,113
-13.4%
|
8.23
|
58,535
USD
|
|
|
2023-09-13 |
2023-09-11 |
S
Sale
|
Cha Albert
Non-Executive Director
|
18,000
-100.0%
10.50
189,050
USD
|
18,000
-100.0%
|
10.50
|
189,050
USD
|
|
|
2023-08-21 |
2023-08-18 |
S
Sale
|
Audhya Paul K.
Chief Medical Officer
Officer
|
8,020
-23.6%
10.73
86,045
USD
|
8,020
-23.6%
|
10.73
|
86,045
USD
|
|
|
2023-08-21 |
2023-08-18 |
S
Sale
|
Yea Christopher
Chief Development Officer
Officer
|
7,142
-14.6%
10.73
76,624
USD
|
7,142
-14.6%
|
10.73
|
76,624
USD
|
|
|
2023-08-21 |
2023-08-18 |
S
Sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
14,876
-9.2%
10.73
159,602
USD
|
14,876
-9.2%
|
10.73
|
159,602
USD
|
|
|
2023-08-21 |
2023-08-18 |
S
Sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
4,976
-6.4%
10.73
53,386
USD
|
4,976
-6.4%
|
10.73
|
53,386
USD
|
|
|
2023-08-21 |
2023-08-18 |
S
Sale
|
Palleiko Benjamin L
President, CFO, CBO & Sec'y
Officer
|
13,067
-12.1%
10.73
140,192
USD
|
13,067
-12.1%
|
10.73
|
140,192
USD
|
|
|
2023-05-19 |
2023-05-18 |
S
Sale
|
Audhya Paul K.
Chief Medical Officer
Officer
|
2,780
-17.6%
10.14
28,201
USD
|
2,780
-17.6%
|
10.14
|
28,201
USD
|
|
|
2023-05-19 |
2023-05-18 |
S
Sale
|
Yea Christopher
Chief Development Officer
Officer
|
2,604
-6.5%
10.14
26,416
USD
|
2,604
-6.5%
|
10.14
|
26,416
USD
|
|
|
2023-05-19 |
2023-05-18 |
S
Sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
1,786
-2.6%
10.14
18,118
USD
|
1,786
-2.6%
|
10.14
|
18,118
USD
|
|
|
2023-05-19 |
2023-05-18 |
S
Sale
|
Palleiko Benjamin L
President, CFO, CBO & Sec'y
Officer
|
4,037
-4.9%
10.14
40,953
USD
|
4,037
-4.9%
|
10.14
|
40,953
USD
|
|
|
2023-05-19 |
2023-05-18 |
S
Sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
5,627
-4.2%
10.14
57,083
USD
|
5,627
-4.2%
|
10.14
|
57,083
USD
|
|
|
2023-02-23 |
2023-02-17 |
S
Sale
|
Palleiko Benjamin L
President, CFO, CBO & Sec'y
Officer
|
4,954
-6.4%
7.66
37,948
USD
|
4,954
-6.4%
|
7.66
|
37,948
USD
|
|
|
2023-02-23 |
2023-02-17 |
S
Sale
|
Audhya Paul K.
Chief Medical Officer
Officer
|
3,412
-26.7%
7.66
26,136
USD
|
3,412
-26.7%
|
7.66
|
26,136
USD
|
|
|
2023-02-23 |
2023-02-17 |
S
Sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
6,700
-5.2%
7.66
51,322
USD
|
6,700
-5.2%
|
7.66
|
51,322
USD
|
|
|
2023-02-23 |
2023-02-17 |
S
Sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
2,228
-3.3%
7.66
17,066
USD
|
2,228
-3.3%
|
7.66
|
17,066
USD
|
|
|
2023-02-23 |
2023-02-17 |
S
Sale
|
Yea Christopher
Chief Development Officer
Officer
|
2,727
-7.1%
7.66
20,889
USD
|
2,727
-7.1%
|
7.66
|
20,889
USD
|
|
|
2022-11-21 |
2022-11-18 |
S
Sale
|
Palleiko Benjamin L
CFO, CBO & Secretary
Officer
|
722
-1.0%
5.44
3,928
USD
|
722
-1.0%
|
5.44
|
3,928
USD
|
|
|
2022-11-21 |
2022-11-18 |
S
Sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
530
-0.8%
5.44
2,883
USD
|
530
-0.8%
|
5.44
|
2,883
USD
|
|
|
2022-11-21 |
2022-11-18 |
S
Sale
|
Yea Christopher
Chief Development Officer
Officer
|
1,139
-3.2%
5.44
6,196
USD
|
1,139
-3.2%
|
5.44
|
6,196
USD
|
|
|
2022-11-21 |
2022-11-18 |
S
Sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
1,785
-1.5%
5.44
9,710
USD
|
1,785
-1.5%
|
5.44
|
9,710
USD
|
|
|
2022-11-21 |
2022-11-18 |
S
Sale
|
Audhya Paul K.
Chief Medical Officer
Officer
|
722
-10.8%
5.44
3,928
USD
|
722
-10.8%
|
5.44
|
3,928
USD
|
|
|
2022-09-07 |
2022-09-02 |
PS
Planned sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
1,320
-1.2%
17.01
22,458
USD
|
1,320
-1.2%
|
17.01
|
22,458
USD
|
|
|
2022-08-19 |
2022-08-17 |
S
Sale
|
Audhya Paul K.
Chief Medical Officer
Officer
|
725
-30.0%
14.96
10,847
USD
|
725
-30.0%
|
14.96
|
10,847
USD
|
|
|
2022-08-19 |
2022-08-17 |
S
Sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
1,797
-1.6%
14.96
26,890
USD
|
1,797
-1.6%
|
14.96
|
26,890
USD
|
|
|
2022-08-19 |
2022-08-17 |
S
Sale
|
Palleiko Benjamin L
CFO, CBO & Secretary
Officer
|
725
-1.1%
14.96
10,847
USD
|
725
-1.1%
|
14.96
|
10,847
USD
|
|
|
2022-08-19 |
2022-08-17 |
S
Sale
|
Yea Christopher
Chief Development Officer
Officer
|
1,145
-3.3%
14.96
17,130
USD
|
1,145
-3.3%
|
14.96
|
17,130
USD
|
|
|
2022-08-19 |
2022-08-17 |
S
Sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
532
-0.9%
14.96
7,960
USD
|
532
-0.9%
|
14.96
|
7,960
USD
|
|
|
2022-03-11 |
2022-03-09 |
PS
Planned sale
|
Crockett Thomas Andrew
CEO
Executive Director
|
10,000
-8.0%
17.07
170,693
USD
|
10,000
-8.0%
|
17.07
|
170,693
USD
|
|
|
2021-11-03 |
2021-11-01 |
PS
Planned sale
|
Yea Christopher
Chief Development Officer
Officer
|
5,000
-13.2%
18.07
90,328
USD
|
5,000
-13.2%
|
18.07
|
90,328
USD
|
|
|
2021-11-03 |
2021-11-01 |
PS
Planned sale
|
Feener Edward P.
Chief Scientific Officer
Officer
|
6,000
-72.9%
18.07
108,424
USD
|
6,000
-72.9%
|
18.07
|
108,424
USD
|
|
